Why Farbe Firma is the Top Manufacturer of Nalbuphine HCl Injection
- Maulik Sudani
- Jun 9
- 7 min read
Last Updated: June 9, 2026
TL;DR: Nalbuphine HCl Injection — a sterile aqueous solution of nalbuphine hydrochloride, a strong opioid analgesic with agonist-antagonist activity (kappa-receptor agonist, mu-receptor antagonist), supplied commonly as 10 mg/mL or 20 mg/mL solutions in 1 mL ampoules for intravenous, intramuscular or subcutaneous administration — is a widely used agent for the management of moderate to severe pain, including peri-operative and post-operative pain, as a supplement to balanced anaesthesia and for obstetric analgesia during labour. Nalbuphine produces potent analgesia with a ceiling on respiratory depression and a lower abuse potential than pure mu-agonist opioids, so each ampoule must deliver an exact, sterile, particulate-free dose. Its safety depends on a precise stability-indicating assay, a tightly controlled impurity and oxidative-degradation profile, light and oxygen protection, low particulate and endotoxin, a correctly held slightly acidic citrate-buffered pH and robust ampoule container-closure integrity, and — where the product is scheduled — secure, reconciled controlled-substance handling. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Nalbuphine HCl Injection at our Gujarat, India facility and supplies it to hospital pharmacy, anaesthesia, surgical, obstetric and pain-management services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Opioid analgesic (agonist-antagonist; kappa agonist / mu antagonist) — Nalbuphine HCl Injection manages moderate to severe pain, supplements balanced anaesthesia and provides obstetric and peri-operative analgesia, delivering potent, titratable pain relief with a ceiling on respiratory depression by the intravenous, intramuscular or subcutaneous route.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified nitrogen-purged, light-protected ampoule filling lines, dedicated control of the stability-indicating assay, the impurity profile, citrate-buffered pH, particulate and endotoxin for a light-sensitive aqueous opioid injection, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders, with controlled-substance documentation where the product is scheduled.
End-to-end CDMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready ampoule packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Nalbuphine HCl Injection Demands a Premium Manufacturer
Nalbuphine HCl Injection occupies an important place in anaesthesia, surgery, obstetrics, emergency medicine and pain management across every market. It is the agonist-antagonist opioid that clinicians reach for when pain is moderate to severe and a strong, titratable analgesic is needed — in post-operative pain, as a supplement to balanced anaesthesia, for analgesia during labour and delivery, and in acute pain where a ceiling on respiratory depression is clinically attractive. Given intravenously, intramuscularly or subcutaneously, it provides rapid, potent and dose-adjustable pain relief. In each of these settings the dose delivered from each small ampoule must be exact, sterile and reliably the same from unit to unit, because with a potent opioid even small variations in delivered dose matter.
That clinical reality places real demands on the manufacturer. Nalbuphine hydrochloride in aqueous solution is light-sensitive and prone to oxidative degradation, and it is formulated in a narrow, slightly acidic citrate-buffered pH window, so the injectable must stay clear, correctly potent and free of degradation products across shelf life. The assay must be exact; the impurity and oxidative-degradation profile must stay within tight limits; the solution must be particulate-free, low in endotoxin, held at the right buffered pH and protected from light and oxygen, then sealed in an ampoule whose integrity is verified. And because nalbuphine is an opioid whose controlled-substance status varies by country, a serious manufacturer handles it under secure, reconciled conditions wherever scheduling requires. Choosing a Nalbuphine HCl Injection manufacturer that treats the stability-indicating assay, light and oxidation control, impurity profiling, pH control, particulate and endotoxin control and container-closure integrity as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Nalbuphine HCl Injection Manufacturer Apart
A world-class manufacturer of Nalbuphine HCl Injection invests in three areas that weaker suppliers underfund: a precise, stability-indicating assay of nalbuphine together with tight control of its oxidative related-substance and degradation-product profile by HPLC, robust aseptic filling of a light-sensitive, oxidation-prone aqueous solution into ampoules under inert-gas (nitrogen) protection with verified container-closure integrity, and tender-ready dossier support for a product procured largely through hospital-formulary, anaesthesia and ministry-of-health channels. It starts with the active — pharmacopoeial-grade nalbuphine hydrochloride sourced from qualified, audited API makers, with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production.
Formulation, filling and sealing then have to defend both the assay and the dose. The bulk solution is compounded in water-for-injection that is purged with nitrogen to displace dissolved oxygen, buffered with citrate to a controlled slightly acidic pH, made isotonic, sterile-filtered through 0.22 µm membrane and filled aseptically into ampoules with nitrogen headspace overlay under light-protected ISO Class 5 conditions. The oxygen-control, light-protection, filling and sealing parameters are locked in the master batch record, because for a potent opioid the assay and the degradation-product profile govern both the efficacy and the safety of every ampoule. Each ampoule is fusion-sealed and 100 % inspected for particulate matter, fill volume, seal quality and cosmetic defects; in-process and release testing confirm nalbuphine assay by validated HPLC, the related-substance profile, pH, clarity of the solution, and endotoxin is held well within limits so the injection is safe for intravenous, intramuscular or subcutaneous administration.
Quality Systems Behind Every Nalbuphine HCl Injection
Every Farbe Firma Nalbuphine HCl Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of nalbuphine against pharmacopoeial reference standards, control of related substances and oxidative degradation products by HPLC, pH and osmolarity, clarity and colour of the solution, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, fill-volume verification and container-closure integrity for the ampoule format. Certificates of analysis are issued with full traceability back to the API lot, the primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated nitrogen-purge and inert-overlay systems, light-protected (low-actinic) compounding and filling areas, calibrated sterilisation and depyrogenation equipment, validated ampoule filling lines with 100 % inspection, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because nalbuphine is light-sensitive and oxidation-prone and its assay drives both efficacy and shelf life, we treat the stability-indicating HPLC assay, the oxidative-degradation result and the solution clarity as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions, with ICH Q1B photostability challenge, and the product is protected from light and oxygen through nitrogen overlay, amber glass and its secondary packaging.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Nalbuphine HCl Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across analgesic, anaesthetic, critical-care, anti-infective and supportive-care categories. For Nalbuphine HCl Injection specifically, we supply 10 mg/mL and 20 mg/mL solutions in 1 mL ampoules under WHO-GMP conditions, with country-specific strengths, fill volumes, tamper-evident packs and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the stability-indicating-assay and oxidative-impurity data package — ready to hand for registration and tender qualification.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping, logistics and — where nalbuphine is scheduled — the import/export and controlled-substance documentation the destination market requires. When a buyer needs Nalbuphine HCl Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, light-protected artwork, filling-line slot and shipment plan delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the filling suite; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, stability-indicating assay development, oxidative-degradation and related-substance control, nitrogen-purge and light-protection strategy, citrate-buffered pH and tonicity, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For a potent agonist-antagonist opioid where assay accuracy, light and oxidation control directly govern both effect and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Nalbuphine HCl Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Nalbuphine HCl Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, nitrogen-purged and light-protected filling, qualified ampoule filling lines, qualified water-for-injection systems, 100 % ampoule inspection and continuous environmental monitoring.
Which strengths and pack sizes of Nalbuphine HCl Injection do you supply?
Our standard presentations are 10 mg/mL and 20 mg/mL sterile aqueous solutions in 1 mL ampoules. Custom strengths, fill volumes, tamper-evident ampoule counts per pack and country-specific artwork are available under contract manufacturing agreements.
Why are light and oxygen protection important for Nalbuphine HCl Injection?
Nalbuphine hydrochloride in solution is light-sensitive and oxidises readily, which can cause discolouration and loss of potency. Farbe Firma compounds under nitrogen purge with inert headspace overlay, buffers the solution with citrate to a controlled slightly acidic pH, fills under light-protected conditions and presents the product in amber glass, with ICH Q1B photostability data in the dossier to support shelf life and handling.
Can Farbe Firma support country-specific registrations for Nalbuphine HCl Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia, including controlled-substance documentation where nalbuphine is scheduled.
What is the minimum order quantity for Nalbuphine HCl Injection contract manufacturing?
MOQs vary by strength, ampoule size, fill volume, label complexity and dossier requirements. For our ampoule presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments